The duration and severity of COVID-19 are related to age, comorbidities, and cytokine
synthesis. This study evaluated the impact of these factors on patients with clinical …

Objectives The coordinated immune response of the host is the key of the successful combat
of the body against SARS-CoV-2 infection and is decisive for the development and …

Objective To delineate the characteristics and clinical significance of plasma inflammatory
cytokines altered in COVID-19. Design Retrospective, single-centre cohort study. Setting …

Since the outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China, it has rapidly
spread across many other countries. While the majority of patients were considered mild …

Coronavirus disease 2019 (COVID-19) broke out and then became a global epidemic at the
end of 2019. With the increasing number of deaths, early identification of disease severity …

Aim COVID-19 pandemic has caused extensive burden on public life and health care
worldwide. This study aimed to assess circulating levels of inflammatory cytokines in adult …

Background. To investigate the association between interleukins (IL‐1β, IL‐2, IL‐4, IL‐6, IL‐
8, and IL‐10) and the disease severity of coronavirus disease 2019 (COVID‐19). Materials …

The widespread prevalence of coronavirus disease-2019 (COVID-19) which is caused by
severe respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, has resulted in a severe …

The cytokine release syndrome has been proposed as the driver of inflammation in
coronavirus disease 2019 (COVID-19). However, studies on longitudinal cytokine profiles in …

Effective laboratory markers for the estimation of disease severity and predicting the clinical
progression of coronavirus disease-2019 (COVID-19) is urgently needed. Laboratory tests …